Crizotinib

Nat Rev Drug Discov. 2011 Dec 1;10(12):897-8. doi: 10.1038/nrd3600.
No abstract available

Publication types

  • News

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Carcinoma, Non-Small-Cell Lung / enzymology
  • Clinical Trials as Topic / methods
  • Crizotinib
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / enzymology
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / pharmacokinetics
  • Protein Kinase Inhibitors / therapeutic use*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrazoles / chemistry
  • Pyrazoles / pharmacokinetics
  • Pyrazoles / therapeutic use*
  • Pyridines / chemistry
  • Pyridines / pharmacokinetics
  • Pyridines / therapeutic use*

Substances

  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyridines
  • Crizotinib
  • Protein-Tyrosine Kinases